Transcutaneous pacing: Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation

Lawrence S. Klein, William M. Miles, James J. Heger, Douglas P. Zipes

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Noninvasive transcutaneous pacing has been used successfully in situations requiring emergent ventricular pacing,1-8 and has also been used to terminate ventricular (VT) or supraventricular tachycardia in some patients.9-13 Thus, transcutaneous pacing might logically be considered a suitable noninvasive substitute for endocardial pacing during programmed electrical stimulation studies. We therefore determined the following features of transcutaneous pacing using the Zoll noninvasive temporary pacemaker (Zoll NTP, ZMI Corp.): patient tolerance, which cardiac chambers were paced, the ventricular effective refractory period (ERP) compared with that determined by endocardial pacing and feasibility for programmed electrical stimulation in patients with ventricular tachyarrhythmias.

Original languageEnglish (US)
Pages (from-to)1126-1129
Number of pages4
JournalThe American journal of cardiology
Volume62
Issue number16
DOIs
StatePublished - Nov 15 1988

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Transcutaneous pacing: Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation'. Together they form a unique fingerprint.

Cite this